Dashboard
Manage Tickers

CMPXCompass Therapeutics, Inc.

Nasdaq compasstherapeutics.com


$ 1.30 $ 0.02 (1.55 %)    

Thursday, 06-Jun-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 463.32 $ -0.16 (-0.03 %)
DIA $ 389.27 $ 0.80 (0.21 %)
SPY $ 534.63 $ -0.01 (0 %)
TLT $ 93.23 $ -0.14 (-0.15 %)
GLD $ 219.44 $ 1.61 (0.74 %)
$ 1.31
$ 1.32
$ 0.00 x 0
$ 0.00 x 0
$ 1.30 - $ 1.39
$ 1.15 - $ 3.45
164,568
na
180.24M
$ 0.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-01-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-18-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 03-05-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 06-08-2020 03-31-2020 10-K
18 02-14-2020 12-31-2019 10-Q
19 11-13-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 07-01-2019 03-31-2019 10-K
22 02-14-2019 12-31-2018 10-Q
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-compass-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Comp...
06/03/2024 11:00:51

HC Wainwright & Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:CMPX) with a Buy and maintains $10 ...

compass-therapeutics-appoints-thomas-schuetz-as-president-and-ceo-effective-may-28-2024-vered-bisker-leib-has-stepped-down
Compass Therapeutics Appoints Thomas Schue...
05/28/2024 20:13:06

Bisker-Leib will continue to be available to the Company as a Senior Consultant for the next 15 months.

hc-wainwright--co-reiterates-buy-on-compass-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Comp...
05/16/2024 15:47:45

HC Wainwright & Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:CMPX) with a Buy and maintains $10 ...

hc-wainwright--co-reiterates-buy-on-compass-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Comp...
05/14/2024 14:50:48

HC Wainwright & Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:CMPX) with a Buy and maintains $10 ...

compass-therapeutics-q1-eps-008-beats-011-estimate
Compass Therapeutics Q1 EPS $(0.08) Beats ...
05/13/2024 12:21:43

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 20:31:24

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/26/2024 20:31:15

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/25/2024 12:06:47

compass-therapeutics-receives-fda-fast-track-designation-for-the-investigation-of-ctx-009-in-combination-with-paclitaxel-for-the-treatment-of-patients-with-metastatic-or-locally-advanced-biliary-tract-tumors-that-have-been-previously-treated
Compass Therapeutics Receives FDA Fast Tra...
04/25/2024 12:01:49

CTX-009, the Company's bispecific DLL4/VEGF-A antibody, in combination with paclitaxel, has shown promising clinical respon...

hc-wainwright--co-reiterates-buy-on-compass-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Comp...
04/16/2024 16:20:43

HC Wainwright & Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:CMPX) with a Buy and maintains $10 ...

compass-therapeutics-announces-first-patient-dosed-in-phase-1-study-of-ctx-8371-in-patients-with-solid-tumors
Compass Therapeutics Announces First Patie...
04/16/2024 12:17:13

compass-therapeutics-presents-data-demonstrating-elimination-of-mhc-class-i-negative-tumors-in-models-at-2024-aacr-annual-meeting
Compass Therapeutics Presents Data Demonst...
04/09/2024 16:01:18

Major Histocompatibility Complex Class I (MHC-I) negative tumors are refractory to immune-oncology therapies, including resista...

wedbush-reiterates-outperform-on-compass-therapeutics-maintains-8-price-target
Wedbush Reiterates Outperform on Compass T...
03/22/2024 13:58:06

Wedbush analyst Robert Driscoll reiterates Compass Therapeutics (NASDAQ:CMPX) with a Outperform and maintains $8 price target.

hc-wainwright--co-maintains-buy-on-compass-therapeutics-maintains-10-price-target
HC Wainwright & Co. Maintains Buy on Compa...
03/21/2024 15:15:51

HC Wainwright & Co. analyst Joseph Pantginis maintains Compass Therapeutics (NASDAQ:CMPX) with a Buy and maintains $10 p...

compass-therapeutics-q4-eps-011-misses-009-estimate
Compass Therapeutics Q4 EPS $(0.11) Misses...
03/21/2024 13:01:16

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate o...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
03/13/2024 13:06:03

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/05/2024 21:31:07

compass-therapeutics-publishes-ctx-8371-preclinical-data-in-oncoimmunology-advancing-to-first-in-human-clinical-trial
Compass Therapeutics Publishes CTX-8371 Pr...
02/28/2024 13:13:56

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/27/2024 21:31:08

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 21:31:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION